KRYXANA®


Film-coated tablets
scheduling status
S4
registration number
52/26/0356
What KRYXANA® contains
Ribociclib succinate, equivalent to 200 mg ribociclib.
other ingredients
Tablet core Microcrystalline cellulose Crospovidone type A Low-substituted hydroxypropylcellulose Magnesium stearate Colloidal anhydrous silica Film coating Iron oxide black (E172) Iron oxide red (E172) Soya lecithin (E322) Polyvinyl alcohol (partially hydrolysed) Talc Titanium dioxide (E171) Xanthan gum.
Therapeutic classification
L01EF02.
© 2026 SAHPRA. ALL RIGHTS RESERVED